160results about How to "Prevent and reduce occurrence" patented technology

A method of treating a brain disorder by heat transfer from brain tissue comprising the steps of surgically cutting a heat transfer aperture into a patient's skull, thereby exposing a predetermined portion of patient's brain; surgically implanting into said heat transfer aperture a heat pump having one or more electrical sensor elements and one or more temperature sensor elements; surgically implanting a heat transfer management unit in a body cavity of said patient such that a micro controller of the heat transfer management unit is connected to one or more activity sensor elements and one or more temperature sensor elements contacting brain tissue and connecting the heat transfer management unit to said heat pump via a lead bundle. Optionally, the heat transfer unit may be located external to the patient's body. Responsive to signals from one or more activity or temperature sensor elements, mathematical algorithms of the heat transfer management unit determine abnormal brain activity, causing the heat pump to remove heat from the brain tissue into a heat sink, thereby cooling the predetermined portion of the patient's brain. This technique utilizes acute hypothermia by means of a Peltier cooler or similar device to cool the brain temperature to reduce or prevent seizure initiation and/or propagation. The method may be used in association with brain stimulation and/or drug application to acutely avoid the occurrence of a seizure episode.

A device and a method of use for treating a medical disorder by surgically implanting into a patient at least one sensor element capable of detecting and conveying cell signals: attaching a management unit such that a micro controller of the management unit is connected to at least one sensor element; and connecting the management unit via a lead bundle to at least one treatment device. The treatment device may be an electrical stimulation device, a magnetic stimulation device, a heat transfer device, or a medication delivery device. Responsive to signals from the one or more sensor elements, mathematical algorithms of the management unit use wavelet crosscorrelation analysis to prompt delivery of at least one treatment modality, such heat transfer, current pulses, magnetic stimulation or medication. The medical disorder may arise from the brain, central nervous system or organs and tissues outside of the central nervous system.

In an electronic component, upper surface electrodes are located on one main surface of an insulating substrate of an interposer on which a multilayer ceramic capacitor is mounted. The insulating substrate has substantially the same shape as that of the multilayer ceramic capacitor, viewed from a direction perpendicular or substantially perpendicular to the main surface, and has the multilayer ceramic capacitor mounted thereon so that the length direction of the multilayer ceramic capacitor substantially coincides with the length direction of the insulating substrate. The insulating substrate includes cutouts that include connection electrodes, respectively, and that are located at the four corners viewed from the direction perpendicular or substantially perpendicular to the main surface. The upper surface electrodes on the one main surface are connected via the connection electrodes to lower surface electrodes, respectively, that are located on the other main surface and are connected to a circuit board.

Methods and compositions containing oxytocin or an oxytocin analog, specifically carbetocin, are provided for the prevention and treatment of autism spectrum disorders, related disorders and symptoms of such disorders. The methods and compositions of the invention are effective in the treatment of social withdrawal, eye contact avoidance, repetitive behaviors, anxiety, attention deficit, hyperactivity, depression, loss of speech, verbal communication difficulties, aversion to touch, visual difficulties, comprehension difficulties, and sound and light sensitivity. Additional compositions and methods are provided which employ oxytocin or an oxytocin analog in combination with a secondary or adjunctive therapeutic agent to yield more effective treatment tools against autism spectrum disorders and related disorders.

A responsive cushion system includes a pressure adjustment system and a cushion formed by an array of bladders coupled to the pressure adjustment system. At least two of the bladders are independent from one another such that that each can be independently pressurized and depressurized by the pressure adjustment system. A processor is coupled to the pressure adjustment system and a user interface, and the processor is operable to select a target group of one or more bladders according to data received via a communication interface. The processor is further operable to control the pressure adjustment system to adjust pressurization of bladders outside the target group according to a first pressurization mode, and control the pressure adjustment system to concurrently adjust pressurization of the target group of bladders according to a second, different pressurization mode. At least one of the first and second pressurization modes dynamically changes pressure over time.

An apparatus and method to generate an image in which images having different exposure amounts are generated, and by synthesizing the generated images, a high-sensitivity (or quality) image can be generated. The apparatus to generate an image includes an exposure adjustment unit to adjust an exposure amount, an image generation unit to generate a plurality of images of different exposure amounts and different resolutions, and an image synthesis unit to synthesize the plurality of generated images.

A display device includes a display panel having a curved side or a polygonal side, the display panel including a plurality of pixels in a display region, a gate driver including a plurality of normal stages connected to each other for outputting gate signals to the pixels via a plurality of gate lines, and a plurality of dummy stages between some of the normal stages, and a data driver providing data signals to the pixels via a plurality of data lines.

Occurrence of power supply noise arising in connection with a step-down action at the time of turning on power supply is to be restrained. A step-down unit is provided with a switched capacitor type step-down circuit and a series regulator type step-down circuit, and stepped-down voltage output terminals of the step-down circuits are connected in common. The common connection of the stepped-down voltage output terminals of both step-down circuits makes possible parallel driving of both, selective driving of either or consecutive driving of the two. In the consecutive driving, even if the switched capacitor type step-down circuit is driven after driving the series regulator type step-down circuit first to supply a stepped-down voltage to loads, the switched capacitor type step-down circuit will need only to be compensated for a discharge due to the loads, and a peak of a charge current for capacitors can be kept low. When operation of the switched capacitor type step-down circuit is started, no large rush current arises, and occurrence of noise is restrained.

An electronic component includes a laminated capacitor and a substrate-type terminal on which the laminated capacitor is mounted, with an viscoelastic resin located in a space between the laminated capacitor and the substrate-type terminal. The substrate-type terminal includes a substrate body, component connecting electrodes to mount the laminated capacitor are located on a component mounting surface of the substrate body, and external connecting electrodes to be connected to a circuit board are located on a substrate mounting surface of the substrate body.

A wrap feed arrangement is disclosed for an agricultural harvester having a module-forming chamber. The arrangement includes a conveyor arrangement, which delivers crop to the module-forming chamber, and a module-forming arrangement which, at least in part, builds the module. The conveyor arrangement has a first roll and a first endless member disposed about the first roll for rotation. The module-forming arrangement has a second roll and a second endless member disposed about the second roll for rotation. At least one of the first and second rolls is movable from a first position in which the first and second endless members are disengaged to a second position in which the first and second endless members are engaged.

An anti-wrinkle device is a light-weight, rigid, hollow member ergonomically contoured to fit comfortably in the area between the breasts of a human female. The hollow member is designed to prevent wrinkles from occurring in the cleavage area when women are lying on their shoulders and/or sides while sleeping. The member is covered with a soft, removable washable fabric. A sleeveless top can be worn to hold the member in place.

A driving apparatus for a display device includes: a reference gamma voltage generator configured to generate a reference gamma voltage according to an MTP control signal, a write control signal, and an erase control signal; and a data driver configured to convert a data signal into a data voltage corresponding to the reference gamma voltage. The reference gamma voltage generator includes: a protection unit configured to output a first voltage as a first internal voltage when the MTP control signal is at a first level, and to interrupt the output of the first voltage when the MTP control signal is at a second level; an MTP cell configured to program a bit signal by utilizing the first internal voltage and a second internal voltage according to the write control signal and erase control signal; and a gamma register configured to determine the reference gamma voltage corresponding to the bit signal.

An display device includes a display panel including a plurality of pixels; a scan driver configured to provide scan signals to the pixels; a data driver configured to provide data signals to the pixels; a look-up table (LUT), wherein an efficiency curve indicating a relationship between an accumulated driving time and an efficiency value is stored in the LUT; a lifespan register, wherein an efficiency changing region for deriving the efficiency value of each of the pixels from the LUT is stored in the lifespan register and the lifespan register is configured to accumulatively store deterioration data of the pixels; and a controller configured to derive the accumulated driving time from the lifespan register, to update the efficiency changing region and the LUT based on the accumulated driving time, and to convert input image data into output image data using the efficiency changing region and the LUT.

Controlled release vascular implants, such as vascular grafts, stents, wraps, and gels comprising a biocompatible polymer and all trans retinoic acid (ATRA), or its derivatives, can be used to treat, prevent, or inhibit thrombosis and/or neointimal hyperplasia which may otherwise be induced by prosthetic implantation. In particular, the implants herein can inhibit smooth muscle cell proliferation, neointimal hyperplasia, and upregulate antithrombotic genes and nitric oxide production in the vasculature. Further, the implants are capable of delivering controlled and predictable localized concentrations of ATRA.

An insurance billing computing system determines whether a first health care provider accepts one or more insurance plans of a first insurance provider that insures a patient; receives one or more billing codes that respectively indicate one or more health care services performed by the first health care provider for the patient during a telemedicine session conducted via a first patient computing device and a health care provider computing system; generates at least one insurance claim based at least in part on the one or more billing codes that respectively indicate the one or more health care services performed by the first health care provider for the patient during the telemedicine session; and submits the at least one insurance claim to the first insurance provider via an insurance provider computing system.

A backlight device capable of preventing or reducing, even when an optical sheet bends, occurrence of luminance nonuniformity and/or shades due to the bend. The backlight device 1 controls the properties of light emitted by a light source 12 using two upper and lower diffusion sheets 16, 20 and a lens sheet 18 placed between the diffusion sheets and illuminates the back side of a display panel with the light, in which a space 24 for expansion is provided between the lens sheet 18 and the upper diffusion sheet 20, the space for expansion accommodating a bend of the lens sheet 18 which is caused by expansion due to heat from the light source 12.

Disclosed is an organic light emitting diode display including: a substrate including a display area configured to display an image and a peripheral area surrounding the display area; a plurality of pad wires at the peripheral area of the substrate; and an inspection wire having a zigzag form on the plurality of pad wires.

Compositions and methods for reducing and/or preventing antibiotic-related damage to cells of the inner ear and the kidney are provided. Such compositions and methods reduce or prevent hearing loss and kidney damage resulting from use of antibiotics, such as aminoglycoside antibiotics. The composition also find use in reducing or preventing inner ear and kidney damage associated with anti-neoplastic agents, other therapeutic drugs, and environmental factors.